Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Danielle and Armand sat down to discuss their first year raising twin sons, Grant and Theo, while also managing Danielle’s ra…
For Danielle, the challenge of becoming a first-time mom was multiplied by two. Meet her twins, Grant and Theo.
CSL’s Swiss Talent Acquisition team based in Bern volunteered to improve the local environment in the heart of the capital ci…
CSL, one of Jumar’s founding partners, celebrated the launch of the state-of-the-art facility, designed to help early-stage b…
CSL recognizes patients around the globe who live with bleeding disorders such as hemophilia. Continued innovation and improv…
On Rare Disease Day, CSL brought together a team of volunteers who pedaled during daylight hours to generate energy needed fo…
CSL Chief Sustainability Officer Jeffrey Ball looks ahead to Earth Day on April 22 and shares highlights, including CSL’s ren…
The National Organization for Rare Disorders recently launched a course that explains how a potential treatment becomes an ap…
This essential element in the body’s immune response goes by several names, including “Ig” and “antibodies.” This video and Q…
Watch a short video about the patient journey, including gene therapy.
Rare Disease Day on February 29 offers a chance to show solidarity with the estimated 300 million people living with rare dis…
The global celebration unites rare disease patients and their advocates on February 29. Find out how to show your support.
Americas
Asia Pacific
Middle East
Europe